Done loading dataset
Done loading the ontology
Done loading IC values
OMIM:616900: Scoring completed. Candidates: 209
{\bf Class} & {\bf Power} & {\bf Inclusivity} & & {\bf Exclusivity} & {\bf Specificity} \\
\hline \hline
Severe muscular hypotonia ({\tt HP:0006829}) & 0.8 & 0.67 & 1.0 & 1.0 \\
Developmental regression ({\tt HP:0002376}) & 0.68 & 0.67 & 0.7 & 1.0 \\
Macroglossia ({\tt HP:0000158}) & 0.62 & 0.44 & 1.0 & 0.95 \\
Abnormality of upper lip vermillion ({\tt HP:0011339}) & 0.57 & 0.56 & 0.58 & 0.84 \\
Severe global developmental delay ({\tt HP:0011344}) & 0.57 & 0.56 & 0.58 & 1.0 \\
Skeletal muscle hypertrophy ({\tt HP:0003712}) & 0.52 & 0.44 & 0.62 & 0.78 \\
Small basal ganglia ({\tt HP:0012697}) & 0.5 & 0.33 & 1.0 & 1.0 \\
Exaggerated cupid's bow ({\tt HP:0002263}) & 0.5 & 0.33 & 1.0 & 1.0 \\
Hypoplasia of the corpus callosum ({\tt HP:0002079}) & 0.48 & 0.44 & 0.52 & 1.0 \\
Coarse facial features ({\tt HP:0000280}) & 0.48 & 0.44 & 0.52 & 1.0 \\
Cerebral white matter hypoplasia ({\tt HP:0012430}) & 0.48 & 0.44 & 0.52 & 1.0 \\
Profound global developmental delay ({\tt HP:0012736}) & 0.45 & 0.33 & 0.7 & 1.0 \\
Prominent nasal bridge ({\tt HP:0000426}) & 0.45 & 0.33 & 0.7 & 1.0 \\
Abnormality of the basal ganglia ({\tt HP:0002134}) & 0.45 & 0.33 & 0.7 & 0.68 \\
Reduced tendon reflexes ({\tt HP:0001315}) & 0.42 & 0.56 & 0.34 & 0.78 \\
Aplasia/Hypoplasia of the corpus callosum ({\tt HP:0007370}) & 0.42 & 0.44 & 0.4 & 0.95 \\
Respiratory insufficiency ({\tt HP:0002093}) & 0.42 & 0.44 & 0.4 & 0.81 \\
Aplasia/Hypoplasia of the cerebral white matter ({\tt HP:0012429}) & 0.42 & 0.44 & 0.4 & 0.95 \\
Thin corpus callosum ({\tt HP:0033725}) & 0.42 & 0.44 & 0.4 & 0.92 \\
Abnormal tongue morphology ({\tt HP:0030809}) & 0.39 & 0.44 & 0.35 & 0.69 \\
Abnormality of the tongue ({\tt HP:0000157}) & 0.39 & 0.44 & 0.35 & 0.65 \\
Areflexia ({\tt HP:0001284}) & 0.38 & 0.33 & 0.45 & 0.85 \\
Absent speech ({\tt HP:0001344}) & 0.38 & 0.56 & 0.29 & 1.0 \\
Open mouth ({\tt HP:0000194}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Tented upper lip vermilion ({\tt HP:0010804}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Diffuse cerebral atrophy ({\tt HP:0002506}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Diffuse cerebellar atrophy ({\tt HP:0100275}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Sloping forehead ({\tt HP:0000340}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Global brain atrophy ({\tt HP:0002283}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Cerebral atrophy ({\tt HP:0002059}) & 0.36 & 0.33 & 0.38 & 0.83 \\
Aplasia/Hypoplasia of the cerebellar vermis ({\tt HP:0006817}) & 0.36 & 0.33 & 0.38 & 0.87 \\
Small forehead ({\tt HP:0000350}) & 0.36 & 0.33 & 0.38 & 1.0 \\
Narrow forehead ({\tt HP:0000341}) & 0.36 & 0.33 & 0.38 & 1.0 \\
Highly arched eyebrow ({\tt HP:0002553}) & 0.36 & 0.33 & 0.38 & 1.0 \\
Cerebellar vermis hypoplasia ({\tt HP:0001320}) & 0.36 & 0.33 & 0.38 & 0.95 \\
Abnormality of muscle size ({\tt HP:0030236}) & 0.35 & 0.44 & 0.29 & 0.64 \\
Atrophy/Degeneration affecting the cerebrum ({\tt HP:0007369}) & 0.33 & 0.33 & 0.33 & 0.77 \\
Abnormal corpus callosum morphology ({\tt HP:0001273}) & 0.33 & 0.44 & 0.26 & 0.83 \\
Partial agenesis of the corpus callosum ({\tt HP:0001338}) & 0.33 & 0.22 & 0.62 & 1.0 \\
Abnormal cerebellar vermis morphology ({\tt HP:0002334}) & 0.31 & 0.33 & 0.29 & 0.79 \\
Cerebellar hypoplasia ({\tt HP:0001321}) & 0.31 & 0.33 & 0.29 & 0.89 \\
Brain atrophy ({\tt HP:0012444}) & 0.31 & 0.33 & 0.29 & 0.77 \\
Agenesis of corpus callosum ({\tt HP:0001274}) & 0.3 & 0.22 & 0.45 & 1.0 \\
Abnormality of hindbrain morphology ({\tt HP:0011282}) & 0.3 & 0.56 & 0.2 & 0.64 \\
Abnormal metencephalon morphology ({\tt HP:0011283}) & 0.3 & 0.56 & 0.2 & 0.64 \\
Abnormal cerebellum morphology ({\tt HP:0001317}) & 0.3 & 0.56 & 0.2 & 0.65 \\
Ventriculomegaly ({\tt HP:0002119}) & 0.29 & 0.44 & 0.22 & 0.84 \\
Aplasia/Hypoplasia of the cerebellum ({\tt HP:0007360}) & 0.29 & 0.33 & 0.25 & 0.83 \\
Abnormal lip morphology ({\tt HP:0000159}) & 0.29 & 0.67 & 0.18 & 0.63 \\
Global developmental delay ({\tt HP:0001263}) & 0.28 & 1.0 & 0.17 & 0.89 \\
Abnormal eyebrow morphology ({\tt HP:0000534}) & 0.28 & 0.56 & 0.19 & 0.74 \\
Delayed skeletal maturation ({\tt HP:0002750}) & 0.27 & 0.22 & 0.35 & 0.95 \\
Abnormality of skeletal maturation ({\tt HP:0000927}) & 0.27 & 0.22 & 0.35 & 0.89 \\
Seizure ({\tt HP:0001250}) & 0.27 & 0.78 & 0.16 & 0.46 \\
Abnormal cerebral white matter morphology ({\tt HP:0002500}) & 0.26 & 0.44 & 0.19 & 0.68 \\
Abnormal cerebral ventricle morphology ({\tt HP:0002118}) & 0.26 & 0.44 & 0.19 & 0.71 \\
Abnormality of upper lip ({\tt HP:0000177}) & 0.26 & 0.56 & 0.17 & 0.69 \\
Cerebellar atrophy ({\tt HP:0001272}) & 0.25 & 0.22 & 0.29 & 0.84 \\
Hypotonia ({\tt HP:0001252}) & 0.25 & 0.89 & 0.14 & 0.81 \\
Abnormal facial shape ({\tt HP:0001999}) & 0.24 & 0.67 & 0.15 & 0.72 \\
Abnormality of the forehead ({\tt HP:0000290}) & 0.24 & 0.67 & 0.15 & 0.71 \\
Abnormality of the cerebral subcortex ({\tt HP:0010993}) & 0.24 & 0.44 & 0.16 & 0.6 \\
EEG abnormality ({\tt HP:0002353}) & 0.23 & 0.22 & 0.24 & 0.59 \\
Abnormality of central nervous system electrophysiology ({\tt HP:0030178}) & 0.23 & 0.22 & 0.24 & 0.57 \\
Bulbous nose ({\tt HP:0000414}) & 0.23 & 0.22 & 0.24 & 1.0 \\
Abnormality of the external nose ({\tt HP:0010938}) & 0.23 & 0.56 & 0.14 & 0.68 \\
Abnormal reflex ({\tt HP:0031826}) & 0.23 & 0.56 & 0.14 & 0.66 \\
Atrophy/Degeneration affecting the central nervous system ({\tt HP:0007367}) & 0.23 & 0.44 & 0.15 & 0.69 \\
Deeply set eye ({\tt HP:0000490}) & 0.22 & 0.33 & 0.17 & 1.0 \\
Delayed speech and language development ({\tt HP:0000750}) & 0.21 & 0.56 & 0.13 & 0.84 \\
Language impairment ({\tt HP:0002463}) & 0.2 & 0.56 & 0.12 & 0.83 \\
Central adrenal insufficiency ({\tt HP:0011734}) & 0.2 & 0.11 & 1.0 & 0.89 \\
Microcytic anemia ({\tt HP:0001935}) & 0.2 & 0.11 & 1.0 & 0.95 \\
Hypokinesia ({\tt HP:0002375}) & 0.2 & 0.11 & 1.0 & 0.95 \\
Diminished movement ({\tt HP:0002374}) & 0.2 & 0.11 & 1.0 & 0.89 \\
Abnormal tongue physiology ({\tt HP:0030810}) & 0.2 & 0.11 & 1.0 & 0.84 \\
Abnormality of the septum pellucidum ({\tt HP:0007375}) & 0.2 & 0.11 & 1.0 & 0.92 \\
Myokymia ({\tt HP:0002411}) & 0.2 & 0.11 & 1.0 & 0.92 \\
Oligohydramnios ({\tt HP:0001562}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Ventilator dependence with inability to wean ({\tt HP:0005946}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Turricephaly ({\tt HP:0000262}) & 0.2 & 0.11 & 1.0 & 0.95 \\
EMG: myokymic discharges ({\tt HP:0100288}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Hyperthyroidism ({\tt HP:0000836}) & 0.2 & 0.11 & 1.0 & 0.87 \\
Status epilepticus ({\tt HP:0002133}) & 0.2 & 0.11 & 1.0 & 0.72 \\
Os odontoideum ({\tt HP:0005667}) & 0.2 & 0.11 & 1.0 & 0.95 \\
Neoplasm of fatty tissue ({\tt HP:0200013}) & 0.2 & 0.11 & 1.0 & 0.83 \\
lipomatous tumor ({\tt HP:0012031}) & 0.2 & 0.11 & 1.0 & 0.83 \\
lipoma ({\tt HP:0012032}) & 0.2 & 0.11 & 1.0 & 0.89 \\
Enlarged cisterna magna ({\tt HP:0002280}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Absent septum pellucidum ({\tt HP:0001331}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Tongue fasciculations ({\tt HP:0001308}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Respiratory failure requiring assisted ventilation ({\tt HP:0004887}) & 0.2 & 0.11 & 1.0 & 0.95 \\
Neurogenic bladder ({\tt HP:0000011}) & 0.2 & 0.11 & 1.0 & 1.0 \\
Abnormal hair morphology ({\tt HP:0001595}) & 0.2 & 0.56 & 0.12 & 0.54 \\
Abnormal muscle tone ({\tt HP:0003808}) & 0.19 & 0.89 & 0.11 & 0.68 \\
Abnormality of skin adnexa morphology ({\tt HP:0011138}) & 0.18 & 0.56 & 0.11 & 0.47 \\
Abnormality of the anterior pituitary ({\tt HP:0011747}) & 0.18 & 0.11 & 0.45 & 0.69 \\
Abnormality of adrenal physiology ({\tt HP:0011733}) & 0.18 & 0.11 & 0.45 & 0.77 \\
Fasciculations ({\tt HP:0002380}) & 0.18 & 0.11 & 0.45 & 0.92 \\
Enlarged posterior fossa ({\tt HP:0005445}) & 0.18 & 0.11 & 0.45 & 0.95 \\
Abnormal growth hormone level ({\tt HP:0032367}) & 0.18 & 0.11 & 0.45 & 0.92 \\
Muscle fibrillation ({\tt HP:0010546}) & 0.18 & 0.11 & 0.45 & 0.92 \\
Mandibular prognathia ({\tt HP:0000303}) & 0.18 & 0.11 & 0.45 & 1.0 \\
CNS demyelination ({\tt HP:0007305}) & 0.18 & 0.11 & 0.45 & 0.89 \\
Abnormal blood sodium concentration ({\tt HP:0010931}) & 0.18 & 0.11 & 0.45 & 0.95 \\
Abnormal blood monovalent inorganic cation concentration ({\tt HP:0010930}) & 0.18 & 0.11 & 0.45 & 0.89 \\
Hyponatremia ({\tt HP:0002902}) & 0.18 & 0.11 & 0.45 & 1.0 \\
Anemia of inadequate production ({\tt HP:0010972}) & 0.18 & 0.11 & 0.45 & 0.75 \\
Small cerebral cortex ({\tt HP:0002472}) & 0.18 & 0.11 & 0.45 & 1.0 \\
Brachycephaly ({\tt HP:0000248}) & 0.18 & 0.11 & 0.45 & 0.95 \\
Respiratory failure ({\tt HP:0002878}) & 0.18 & 0.11 & 0.45 & 1.0 \\
Abnormality of the odontoid process ({\tt HP:0003310}) & 0.18 & 0.11 & 0.45 & 0.87 \\
Esodeviation ({\tt HP:0020045}) & 0.18 & 0.11 & 0.45 & 0.78 \\
Hypopituitarism ({\tt HP:0040075}) & 0.18 & 0.11 & 0.45 & 0.84 \\
Generalized-onset seizure ({\tt HP:0002197}) & 0.18 & 0.11 & 0.45 & 0.77 \\
Abnormality of the adrenal glands ({\tt HP:0000834}) & 0.18 & 0.11 & 0.45 & 0.69 \\
Anterior hypopituitarism ({\tt HP:0000830}) & 0.18 & 0.11 & 0.45 & 0.84 \\
Adrenal insufficiency ({\tt HP:0000846}) & 0.18 & 0.11 & 0.45 & 0.85 \\
Poor eye contact ({\tt HP:0000817}) & 0.18 & 0.11 & 0.45 & 1.0 \\
Decreased response to growth hormone stimuation test ({\tt HP:0000824}) & 0.18 & 0.11 & 0.45 & 0.95 \\
Cerebral cortical atrophy ({\tt HP:0002120}) & 0.18 & 0.11 & 0.45 & 0.87 \\
Hypertriglyceridemia ({\tt HP:0002155}) & 0.18 & 0.11 & 0.45 & 1.0 \\
Esotropia ({\tt HP:0000565}) & 0.18 & 0.11 & 0.45 & 0.79 \\
Eczema ({\tt HP:0000964}) & 0.18 & 0.11 & 0.45 & 0.84 \\
Abnormal posterior cranial fossa morphology ({\tt HP:0000932}) & 0.18 & 0.11 & 0.45 & 0.8 \\
Corneal opacity ({\tt HP:0007957}) & 0.18 & 0.11 & 0.45 & 0.78 \\
Neurodevelopmental delay ({\tt HP:0012758}) & 0.17 & 1.0 & 0.09 & 0.73 \\
Aplasia/Hypoplasia of the cerebrum ({\tt HP:0007364}) & 0.17 & 0.56 & 0.1 & 0.8 \\
Abnormality of mouth shape ({\tt HP:0011338}) & 0.17 & 0.22 & 0.13 & 0.83 \\
Abnormality of the nasal tip ({\tt HP:0000436}) & 0.17 & 0.22 & 0.13 & 0.79 \\
Visual impairment ({\tt HP:0000505}) & 0.17 & 0.22 & 0.13 & 0.55 \\
Abnormal nervous system electrophysiology ({\tt HP:0001311}) & 0.17 & 0.22 & 0.13 & 0.57 \\
Aplasia/Hypoplasia involving the central nervous system ({\tt HP:0002977}) & 0.17 & 0.67 & 0.09 & 0.64 \\
Abnormality of the nasal alae ({\tt HP:0000429}) & 0.17 & 0.33 & 0.11 & 0.83 \\
Anteverted nares ({\tt HP:0000463}) & 0.17 & 0.33 & 0.11 & 0.95 \\
Abnormal oral cavity morphology ({\tt HP:0000163}) & 0.16 & 0.89 & 0.09 & 0.42 \\
Aplasia/Hypoplasia of the ribs ({\tt HP:0006712}) & 0.16 & 0.11 & 0.29 & 0.89 \\
Shallow orbits ({\tt HP:0000586}) & 0.16 & 0.11 & 0.29 & 1.0 \\
Peripheral axonal degeneration ({\tt HP:0000764}) & 0.16 & 0.11 & 0.29 & 0.83 \\
Impaired social interactions ({\tt HP:0000735}) & 0.16 & 0.11 & 0.29 & 0.87 \\
Abnormal aortic arch morphology ({\tt HP:0012303}) & 0.16 & 0.11 & 0.29 & 0.72 \\
Asthma ({\tt HP:0002099}) & 0.16 & 0.11 & 0.29 & 0.92 \\
Immunologic hypersensitivity ({\tt HP:0100326}) & 0.16 & 0.11 & 0.29 & 0.67 \\
Bilateral tonic-clonic seizure ({\tt HP:0002069}) & 0.16 & 0.11 & 0.29 & 0.89 \\
Decreased fetal movement ({\tt HP:0001558}) & 0.16 & 0.11 & 0.29 & 1.0 \\
Prenatal movement abnormality ({\tt HP:0001557}) & 0.16 & 0.11 & 0.29 & 0.95 \\
11 pairs of ribs ({\tt HP:0000878}) & 0.16 & 0.11 & 0.29 & 1.0 \\
Peripheral axonal neuropathy ({\tt HP:0003477}) & 0.16 & 0.11 & 0.29 & 0.92 \\
Cerebral visual impairment ({\tt HP:0100704}) & 0.16 & 0.11 & 0.29 & 1.0 \\
EMG abnormality ({\tt HP:0003457}) & 0.16 & 0.11 & 0.29 & 0.77 \\
Neurodegeneration ({\tt HP:0002180}) & 0.16 & 0.11 & 0.29 & 0.95 \\
Broad forehead ({\tt HP:0000337}) & 0.16 & 0.11 & 0.29 & 1.0 \\
Missing ribs ({\tt HP:0000921}) & 0.16 & 0.11 & 0.29 & 0.95 \\
Abnormal social behavior ({\tt HP:0012433}) & 0.16 & 0.11 & 0.29 & 0.81 \\
Abnormal branching pattern of the aortic arch ({\tt HP:0011587}) & 0.16 & 0.11 & 0.29 & 0.77 \\
Right aortic arch ({\tt HP:0012020}) & 0.16 & 0.11 & 0.29 & 0.89 \\
Abnormality of the nares ({\tt HP:0005288}) & 0.16 & 0.33 & 0.1 & 0.83 \\
Abnormal nasal morphology ({\tt HP:0005105}) & 0.16 & 0.56 & 0.09 & 0.69 \\
Abnormality of vision ({\tt HP:0000504}) & 0.15 & 0.22 & 0.12 & 0.52 \\
Abnormal oral morphology ({\tt HP:0031816}) & 0.15 & 0.89 & 0.08 & 0.42 \\
Feeding difficulties ({\tt HP:0011968}) & 0.15 & 0.33 & 0.09 & 0.84 \\
Abnormal ocular adnexa morphology ({\tt HP:0030669}) & 0.15 & 0.67 & 0.08 & 0.5 \\
Abnormality of the ocular adnexa ({\tt HP:0032039}) & 0.15 & 0.67 & 0.08 & 0.49 \\
Neurological speech impairment ({\tt HP:0002167}) & 0.15 & 0.56 & 0.08 & 0.68 \\
Synophrys ({\tt HP:0000664}) & 0.14 & 0.11 & 0.2 & 1.0 \\
Abnormality of thyroid physiology ({\tt HP:0002926}) & 0.14 & 0.11 & 0.2 & 0.69 \\
Abnormal adipose tissue morphology ({\tt HP:0009124}) & 0.14 & 0.11 & 0.2 & 0.67 \\
Focal-onset seizure ({\tt HP:0007359}) & 0.14 & 0.11 & 0.2 & 0.51 \\
Large forehead ({\tt HP:0002003}) & 0.14 & 0.11 & 0.2 & 1.0 \\
Gingival overgrowth ({\tt HP:0000212}) & 0.14 & 0.11 & 0.2 & 1.0 \\
Abnormality of the hypothalamus-pituitary axis ({\tt HP:0000864}) & 0.14 & 0.11 & 0.2 & 0.65 \\
Abnormality of the thyroid gland ({\tt HP:0000820}) & 0.14 & 0.11 & 0.2 & 0.62 \\
Abnormality of the pituitary gland ({\tt HP:0012503}) & 0.14 & 0.11 & 0.2 & 0.65 \\
Abnormality of bony orbit of skull ({\tt HP:3000030}) & 0.14 & 0.11 & 0.2 & 0.92 \\
Osteoporosis ({\tt HP:0000939}) & 0.14 & 0.11 & 0.2 & 0.92 \\
Facial hypertrichosis ({\tt HP:0002219}) & 0.14 & 0.11 & 0.2 & 0.95 \\
Abnormality of the skull base ({\tt HP:0002693}) & 0.14 & 0.11 & 0.2 & 0.77 \\
Hypertrichosis ({\tt HP:0000998}) & 0.14 & 0.22 & 0.11 & 0.81 \\
Abnormal nasal bridge morphology ({\tt HP:0000422}) & 0.14 & 0.33 & 0.09 & 0.83 \\
Abnormality of the mouth ({\tt HP:0000153}) & 0.14 & 0.89 & 0.07 & 0.42 \\
Abnormal muscle physiology ({\tt HP:0011804}) & 0.14 & 0.89 & 0.07 & 0.52 \\
Generalized hypotonia ({\tt HP:0001290}) & 0.13 & 0.33 & 0.08 & 0.95 \\
Abnormality of the nose ({\tt HP:0000366}) & 0.13 & 0.56 & 0.07 & 0.53 \\
Anemia ({\tt HP:0001903}) & 0.13 & 0.11 & 0.15 & 0.66 \\
Aplasia/Hypoplasia involving bones of the thorax ({\tt HP:0006711}) & 0.13 & 0.11 & 0.15 & 0.76 \\
Abnormal erythroid lineage cell morphology ({\tt HP:0012130}) & 0.13 & 0.11 & 0.15 & 0.92 \\
Abnormality of the ribs ({\tt HP:0000772}) & 0.13 & 0.11 & 0.15 & 0.65 \\
Abnormality of the chin ({\tt HP:0000306}) & 0.13 & 0.11 & 0.15 & 0.78 \\
Abnormal blood cation concentration ({\tt HP:0010929}) & 0.13 & 0.11 & 0.15 & 0.72 \\
Abnormality of the diencephalon ({\tt HP:0010662}) & 0.13 & 0.11 & 0.15 & 0.73 \\
Heterotropia ({\tt HP:0032012}) & 0.13 & 0.11 & 0.15 & 0.7 \\
Reduced bone mineral density ({\tt HP:0004349}) & 0.13 & 0.11 & 0.15 & 0.8 \\
Abnormality of bone mineral density ({\tt HP:0004348}) & 0.13 & 0.11 & 0.15 & 0.57 \\
Abnormal erythrocyte morphology ({\tt HP:0001877}) & 0.13 & 0.11 & 0.15 & 0.55 \\
Abnormal blood ion concentration ({\tt HP:0003111}) & 0.13 & 0.11 & 0.15 & 0.69 \\
Neurodevelopmental abnormality ({\tt HP:0012759}) & 0.12 & 1.0 & 0.06 & 0.68 \\
Peripheral neuropathy ({\tt HP:0009830}) & 0.11 & 0.11 & 0.12 & 0.71 \\
Hirsutism ({\tt HP:0001007}) & 0.11 & 0.11 & 0.12 & 0.92 \\
Abnormality of the amniotic fluid ({\tt HP:0001560}) & 0.11 & 0.11 & 0.12 & 0.89 \\
Hyperlipidemia ({\tt HP:0003077}) & 0.11 & 0.11 & 0.12 & 0.95 \\
Hyporeflexia ({\tt HP:0001265}) & 0.11 & 0.11 & 0.12 & 0.85 \\
Abnormal circulating hormone concentration ({\tt HP:0003117}) & 0.11 & 0.11 & 0.12 & 0.58 \\
Abnormality of skin physiology ({\tt HP:0011122}) & 0.11 & 0.11 & 0.12 & 0.6 \\
Inflammatory abnormality of the skin ({\tt HP:0011123}) & 0.11 & 0.11 & 0.12 & 0.64 \\
Optic atrophy ({\tt HP:0000648}) & 0.1 & 0.11 & 0.09 & 1.0 \\
Long philtrum ({\tt HP:0000343}) & 0.1 & 0.11 & 0.09 & 1.0 \\
Hyperreflexia ({\tt HP:0001347}) & 0.1 & 0.11 & 0.09 & 0.77 \\
Abnormal cerebral morphology ({\tt HP:0002060}) & 0.1 & 0.67 & 0.06 & 0.49 \\
Abnormality of digestive system morphology ({\tt HP:0025033}) & 0.1 & 0.89 & 0.05 & 0.48 \\
\end{tabular}
\begin{tabular}{p{5cm}|l|l|l|l}
{\bf OMIM:616900 (9 members)} & {\bf r-score} & {\bf Inclusion} & {\bf Exclusion} & {\bf IC} \\
Severe muscular hypotonia ({\tt HP:0006829}) & 0.8 & 0.67 & 1.0 & 1.0 \\
Developmental regression ({\tt HP:0002376}) & 0.68 & 0.67 & 0.7 & 1.0 \\
Macroglossia ({\tt HP:0000158}) & 0.62 & 0.44 & 1.0 & 0.95 \\
Abnormality of upper lip vermillion ({\tt HP:0011339}) & 0.57 & 0.56 & 0.58 & 0.84 \\
Severe global developmental delay ({\tt HP:0011344}) & 0.57 & 0.56 & 0.58 & 1.0 \\
Skeletal muscle hypertrophy ({\tt HP:0003712}) & 0.52 & 0.44 & 0.62 & 0.78 \\
Small basal ganglia ({\tt HP:0012697}) & 0.5 & 0.33 & 1.0 & 1.0 \\
Exaggerated cupid's bow ({\tt HP:0002263}) & 0.5 & 0.33 & 1.0 & 1.0 \\
Hypoplasia of the corpus callosum ({\tt HP:0002079}) & 0.48 & 0.44 & 0.52 & 1.0 \\
Coarse facial features ({\tt HP:0000280}) & 0.48 & 0.44 & 0.52 & 1.0 \\
Cerebral white matter hypoplasia ({\tt HP:0012430}) & 0.48 & 0.44 & 0.52 & 1.0 \\
Profound global developmental delay ({\tt HP:0012736}) & 0.45 & 0.33 & 0.7 & 1.0 \\
Prominent nasal bridge ({\tt HP:0000426}) & 0.45 & 0.33 & 0.7 & 1.0 \\
Reduced tendon reflexes ({\tt HP:0001315}) & 0.42 & 0.56 & 0.34 & 0.78 \\
Aplasia/Hypoplasia of the corpus callosum ({\tt HP:0007370}) & 0.42 & 0.44 & 0.4 & 0.95 \\
Respiratory insufficiency ({\tt HP:0002093}) & 0.42 & 0.44 & 0.4 & 0.81 \\
Aplasia/Hypoplasia of the cerebral white matter ({\tt HP:0012429}) & 0.42 & 0.44 & 0.4 & 0.95 \\
Thin corpus callosum ({\tt HP:0033725}) & 0.42 & 0.44 & 0.4 & 0.92 \\
Areflexia ({\tt HP:0001284}) & 0.38 & 0.33 & 0.45 & 0.85 \\
Absent speech ({\tt HP:0001344}) & 0.38 & 0.56 & 0.29 & 1.0 \\
Open mouth ({\tt HP:0000194}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Tented upper lip vermilion ({\tt HP:0010804}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Diffuse cerebral atrophy ({\tt HP:0002506}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Diffuse cerebellar atrophy ({\tt HP:0100275}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Sloping forehead ({\tt HP:0000340}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Global brain atrophy ({\tt HP:0002283}) & 0.36 & 0.22 & 1.0 & 1.0 \\
Cerebral atrophy ({\tt HP:0002059}) & 0.36 & 0.33 & 0.38 & 0.83 \\
Aplasia/Hypoplasia of the cerebellar vermis ({\tt HP:0006817}) & 0.36 & 0.33 & 0.38 & 0.87 \\
Small forehead ({\tt HP:0000350}) & 0.36 & 0.33 & 0.38 & 1.0 \\
Narrow forehead ({\tt HP:0000341}) & 0.36 & 0.33 & 0.38 & 1.0 \\
Highly arched eyebrow ({\tt HP:0002553}) & 0.36 & 0.33 & 0.38 & 1.0 \\
Cerebellar vermis hypoplasia ({\tt HP:0001320}) & 0.36 & 0.33 & 0.38 & 0.95 \\
Atrophy/Degeneration affecting the cerebrum ({\tt HP:0007369}) & 0.33 & 0.33 & 0.33 & 0.77 \\
Abnormal corpus callosum morphology ({\tt HP:0001273}) & 0.33 & 0.44 & 0.26 & 0.83 \\
Partial agenesis of the corpus callosum ({\tt HP:0001338}) & 0.33 & 0.22 & 0.62 & 1.0 \\
Abnormal cerebellar vermis morphology ({\tt HP:0002334}) & 0.31 & 0.33 & 0.29 & 0.79 \\
Cerebellar hypoplasia ({\tt HP:0001321}) & 0.31 & 0.33 & 0.29 & 0.89 \\
Brain atrophy ({\tt HP:0012444}) & 0.31 & 0.33 & 0.29 & 0.77 \\
Agenesis of corpus callosum ({\tt HP:0001274}) & 0.3 & 0.22 & 0.45 & 1.0 \\
Ventriculomegaly ({\tt HP:0002119}) & 0.29 & 0.44 & 0.22 & 0.84 \\
Aplasia/Hypoplasia of the cerebellum ({\tt HP:0007360}) & 0.29 & 0.33 & 0.25 & 0.83 \\
Global developmental delay ({\tt HP:0001263}) & 0.28 & 1.0 & 0.17 & 0.89 \\
Abnormal eyebrow morphology ({\tt HP:0000534}) & 0.28 & 0.56 & 0.19 & 0.74 \\
Delayed skeletal maturation ({\tt HP:0002750}) & 0.27 & 0.22 & 0.35 & 0.95 \\
Abnormality of skeletal maturation ({\tt HP:0000927}) & 0.27 & 0.22 & 0.35 & 0.89 \\
Abnormal cerebral ventricle morphology ({\tt HP:0002118}) & 0.26 & 0.44 & 0.19 & 0.71 \\
{\em Overall} & - & 100.0 & - & - \\ 
\hline
\end{tabular}
Classifying 'OMIM:616900' using candidate set with OI: 88.8888888900
Reclassification:
OMIM:616900 AUC: 0.9341448189762797

